Skip to main content
Date :
10 am to 4 pm
 
Thought-provoking discussions with leaders on Next-Gen Therapies, how to prepare to get funding and how AI is changing clinical trials.
  • Do you want to hear and discuss what sector’s most influential thinkers say about next-gen therapies are heading in 2026?
  • Do you want to hear and discuss how AI is changing clinical trial design ?
  • Do you want to hear and discuss how to best prepare yourself for your next funding round?
  • Do you want to hear from biotech leaders about their challenges and experiences, and share yours?

Then this is the event for you!

We have various big picture and analytical business leaders to lead the discussions in Next Gen Therapies, Drug Drug Discovery & Development, How Clinical Trail Design is being changed by AI, how to best prepare your company for the next funding round, and so much more. The full speaker line-up to be announced on the 3 March, you really won't be disappointed!!

The speakers confirmed include:

Sir Tony Kouzarides, PhD, FRS, FMedSci - Director & co-founder, Milner Therapeutics Institute, Professor of Cancer Biology, University of Cambridge, CEO & co-founder, Vellos and Venture Partner, Fifty Years.

Paul Matthews, Institute Director, Rosalind Franklin Institute

Paolo Sicilano and Erik Nordkamp, PA Consulting

Olga Kubassova, President, Image Analysis Group

Peter MacLennan, CEO, TCR Solutions

James Campbell, Commercial Director, Walmer Group

Agata Nyga, CEO, Mechanome Bio

Christopher Peters, Imperial, Biomarker Lead for NIHR

Tom Mander, CEO, Pharmagene

Fin Williams, CEO, Rumii

Anthony Tennyson, CEO, Solvonis

Chatham House Rules apply - "what goes on in the Forum, stays in the Forum - so to speak!"
 

Who Should Attend

The #CreativeDisruption Forum is designed for professionals working in life sciences who are driving innovation and growth. It is ideal for:

  • Founders and executives of biotech
  • R&D and clinical development leaders
  • Investors and business strategists in the life sciences
  • Innovation managers, consultants, and academic partners involved in commercialisation
  • Students and early-career researchers interested in understanding how scientific innovation translates into successful business ventures
Venue and Location Information:
ARC, London